Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Werewolf Therapeutics Inc (HOWL)

Werewolf Therapeutics Inc (HOWL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Werewolf Therapeutics Inc 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 USA

https://werewolftx.com Employees: 46 P: 617-952-0555

Sector:

Medical

Description:

Werewolf Therapeutics Inc. is a biopharmaceutical company. It involved in the development of conditionally activated therapeutics engineered to stimulate the body's immune system for the treatment of cancer. Werewolf Therapeutics Inc. is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 46,575
Enterprise Value, $K -10,475
Shares Outstanding, K 48,597
Float, K 37,128
% Float 76.40%
Short Interest, K 1,402
Short Float 2.88%
Days to Cover 2.82
Short Volume Ratio 0.39
% of Insider Shareholders 23.60%
% of Institutional Shareholders 64.84%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -60,820 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -8,380 K
EBIT, $ -60,680 K
EBITDA, $ -59,050 K

Growth:

1-Year Return 10.99%
3-Year Return -61.66%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.20 on 03/27/26
Next Earnings Date 05/14/26
Earnings Per Share ttm -1.36
EPS Growth vs. Prev Qtr 44.44%
EPS Growth vs. Prev Year 56.52%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

HOWL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -158.81%
Return-on-Assets % -69.75%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.63
Book Value/Share 0.51
Interest Coverage -10.54
60-Month Beta 0.54
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.